(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基芐基)苯基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇

ChemLeader 98+%

Dapagliflozin (BMS-512148; 達格列凈)

產品編號：CL1127 CAS No.：461432-26-8 MDLNo：MFCD13182359 分子式：C21H25ClO6 分子量：408.87

加入收藏分享給朋友

規格	庫存	目錄價	會員專享價	數量
100 mg	In-stock	￥566.00	登錄后可見	- +
250 mg	In-stock	￥788.00	登錄后可見	- +
500 mg	In-stock	￥1488.00	登錄后可見	- +

化學品安全說明書(MSDS)

下載MSDS

質檢證書(COA)

下載COA

發送詢價加入購物車

基本信息
相關文檔
產品詳情
相關文獻

基本信息

英文名稱	Dapagliflozin (BMS-512148; 達格列凈)
中文名稱	(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基芐基)苯基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇
CAS號	461432-26-8
分子式	C21H25ClO6
分子量	408.87
MDL	MFCD13182359
外觀	White to off-white powder
儲存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產品詳情

Dapagliflozin (formerly known as BMS-512148; trade names Farxiga in the US and Forxiga in the EU) is a potent and selective hSGLT2 (sodium-glucose transport proteins) inhibitor with anti-diabetic activity. It inhibits hSGLT2 with an EC50 of 1.1 nM, and exhibits1200-fold selectivity over hSGLT1. Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Urine is the means by which blood glucose is expelled when this transporter mechanism is blocked.

相關文獻

抱歉，暫時沒有相關文獻

相關產品

抱歉，暫時沒有相關產品

瀏覽記錄

CL1127

(2S,3R,4R,5S,6R)-2-(4-氯-3-(4-乙氧基芐基)苯基)-6-(羥甲基)四氫-2H-吡喃-3,4,5-三醇

461432-26-8 98+% In-stock

￥566.00 100 mg